https://www.bostontechnologyreview.com/article/908368739-choosing-a-global-high-purity-fluorinated-building-blocks-vendor-for-modern-labs-aifchem Boston Technology Review en PressRelease 2026-04-27T05:08:32+00:00 Choosing a Global High-Purity Fluorinated Building Blocks Vendor for Modern Labs: AiFChem https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24841275-high-purity-fluorinated-buildin-1116x746.png https://www.bostontechnologyreview.com/article/908368419-strategic-advantages-of-partnering-with-a-global-high-purity-heterocyclic-building-blocks-supplier-aifchem Boston Technology Review en PressRelease 2026-04-27T05:08:09+00:00 Strategic Advantages of Partnering with a Global High-Purity Heterocyclic Building Blocks Supplier: AiFChem https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24841273-global-high-purity-heterocyclic-757x600.png https://www.bostontechnologyreview.com/article/908452232-signnow-launches-docgen-api-to-automate-business-document-creation-and-close-the-gap-between-data-and-signature Boston Technology Review en PressRelease 2026-04-27T13:30:00+00:00 SignNow Launches Docgen API to Automate Business Document Creation and Close the Gap Between Data and Signature https://ml.globenewswire.com/media/aab78b76-7606-4e1a-ac9e-3519885f79d4/medium/docgen-api-by-signnow.png https://www.bostontechnologyreview.com/article/908452251-harvard-apparatus-regenerative-technology-announces-first-patient-treated-with-cellspan-esophageal-implant-at-mayo-clinic Boston Technology Review en PressRelease 2026-04-27T13:30:00+00:00 Harvard Apparatus Regenerative Technology Announces First Patient Treated with Cellspan Esophageal Implant at Mayo Clinic https://ml.globenewswire.com/media/686ae558-8768-4fc3-bdce-87ae3b318dd6/small/hrgn-logo-jpg.jpg https://www.bostontechnologyreview.com/article/908452255-siren-biotechnology-publishes-foundational-aav-immuno-gene-therapy-data-and-announces-presentations-at-asgct-2026 Boston Technology Review en PressRelease 2026-04-27T13:30:00+00:00 Siren Biotechnology Publishes Foundational AAV Immuno-Gene Therapy Data and Announces Presentations at ASGCT 2026 https://ml.globenewswire.com/media/85723172-4ddc-4c45-bfcc-98d753f7563c/small/siren-bio-logo-with-name-png.png https://www.bostontechnologyreview.com/article/908452375-aibotics-crosses-the-line-from-concept-to-cash-flow-as-3dx-industries-commits-to-phill-production Boston Technology Review en PressRelease 2026-04-27T13:30:00+00:00 AIBotics Crosses the Line from Concept to Cash Flow as 3DX Industries Commits to PHILL™ Production https://ml.globenewswire.com/media/ZWQzNTQxODItNzExMi00NWY4LThjOGYtNGFlYmFiODE5YWQzLTEzMDUwNjktMjAyNi0wNC0yNy1lbg==/tiny/AIBotics-Inc-.png https://www.bostontechnologyreview.com/article/908452397-onetrust-appoints-doug-owens-as-chief-financial-officer Boston Technology Review en PressRelease 2026-04-27T13:30:00+00:00 OneTrust Appoints Doug Owens as Chief Financial Officer https://ml.globenewswire.com/media/9e567f43-2639-468b-8768-b4c42448b53e/medium/doug-owens-cfo-onetrust.jpg https://www.bostontechnologyreview.com/article/908452398-correction-satellogic-schedules-first-quarter-fiscal-year-2026-results-conference-call-on-tuesday-may-12-2026-at-8-00-a-m-eastern-time Boston Technology Review en PressRelease 2026-04-27T13:28:20+00:00 CORRECTION - Satellogic Schedules First Quarter Fiscal Year 2026 Results Conference Call on Tuesday, May 12, 2026 at 8:00 a.m. Eastern Time https://ml.globenewswire.com/media/d2d0c386-2a99-4434-aa48-fc69a11ff8a7/small/satellogic-logo-png.png https://www.bostontechnologyreview.com/article/908452311-polyrizon-announces-filing-of-european-patent-application-for-its-breakthrough-drug-delivery-platform Boston Technology Review en PressRelease 2026-04-27T13:28:00+00:00 Polyrizon Announces Filing of European Patent Application for Its Breakthrough Drug Delivery Platform https://ml.globenewswire.com/media/YmQ4YTU5MTctMWM0Mi00ZWRiLTg5MWYtM2JiYzU0ZWQwNGU3LTUwMDEyOTIyMy0yMDI2LTA0LTI3LWVu/tiny/Polyrizon-Ltd-.png https://www.bostontechnologyreview.com/article/908452209-trifetch-comes-out-of-stealth-to-automate-the-administrative-work-that-slows-specialty-clinics Boston Technology Review en PressRelease 2026-04-27T13:17:01+00:00 TriFetch comes out of stealth to automate the administrative work that slows specialty clinics https://ml-eu.globenewswire.com/media/14091c62-c062-4a03-b2c2-8a311bccf18f/small/logo-png.png https://www.bostontechnologyreview.com/article/908452319-other-world-computing-owc-takes-home-videomaker-magazine-s-nab-2026-best-of-show-best-raid-storage-award Boston Technology Review en PressRelease 2026-04-27T13:14:12+00:00 Other World Computing (OWC) Takes Home Videomaker Magazine’s NAB 2026, Best of Show, Best RAID Storage Award https://ml.globenewswire.com/media/e8e6a800-1943-4e64-96a7-63a29ecf768e/medium/owc-express-4m2-ultra-raid.jpg https://www.bostontechnologyreview.com/article/908447625-1kosmos-ceo-hemen-vimadalal-named-entrepreneur-of-the-year-2026-new-jersey-finalist-by-ey-us Boston Technology Review en PressRelease 2026-04-27T13:03:00+00:00 1Kosmos CEO Hemen Vimadalal Named Entrepreneur Of The Year® 2026 New Jersey Finalist by EY US https://ml.globenewswire.com/media/9057bc16-ccbb-48f8-bcfd-1b57d0161cd1/medium/hemen-vimadalal-co-founder-and-ceo-of-1kosmos.jpg https://www.bostontechnologyreview.com/article/908447620-momentive-software-earns-two-stevie-awards-in-the-24th-annual-american-business-awards Boston Technology Review en PressRelease 2026-04-27T13:00:00+00:00 Momentive Software Earns Two Stevie® Awards in the 24th Annual American Business Awards® https://ml.globenewswire.com/media/a4036870-c0e0-42d8-b118-f99a2f5a0bb4/medium/momentive-research-report-wins-bronze-stevie-award.png https://www.bostontechnologyreview.com/article/908447634-asapp-launches-multiple-ai-agents-within-cxp-to-advance-enterprise-customer-service Boston Technology Review en PressRelease 2026-04-27T13:00:00+00:00 ASAPP Launches Multiple AI Agents Within CXP to Advance Enterprise Customer Service https://ml.globenewswire.com/media/47448450-7d01-407d-9f85-734a7ddfa4d0/small/asapplogo-black-png.png https://www.bostontechnologyreview.com/article/908447651-2trust-ai-and-carahsoft-partner-to-bring-ai-governance-solutions-to-the-public-sector Boston Technology Review en PressRelease 2026-04-27T13:00:00+00:00 2Trust.AI and Carahsoft Partner to Bring AI Governance Solutions to the Public Sector https://ml.globenewswire.com/media/ee2f2b02-4089-4a15-93fa-0956daf4ad82/small/carahsoft-blue-logo-web-png.png https://www.bostontechnologyreview.com/article/908447704-human-ad-viewability-measurement-earns-mrc-accreditation-redefining-transparency-explainability-and-trust-in-ad-measurement Boston Technology Review en PressRelease 2026-04-27T13:00:00+00:00 HUMAN Ad Viewability Measurement Earns MRC Accreditation, Redefining Transparency, Explainability, and Trust in Ad Measurement https://ml.globenewswire.com/media/94d62c75-6078-474d-b808-0fb7fb2358a4/medium/human-ad-viewability-measurement-earns-mrc-accreditation.png https://www.bostontechnologyreview.com/article/908447949-goldman-sachs-alternatives-announces-strategic-investment-in-kashable-leading-the-company-s-series-c-equity-round Boston Technology Review en PressRelease 2026-04-27T13:00:00+00:00 Goldman Sachs Alternatives Announces Strategic Investment in Kashable, Leading the Company’s Series C Equity Round https://ml.globenewswire.com/media/5c8e9399-0b18-48e9-9512-a94f9aaccc10/medium/goldman-sachs-alternatives-leads-kashable-s-series-c-equity.jpg https://www.bostontechnologyreview.com/article/908448005-telos-corporation-to-announce-first-quarter-2026-financial-results-on-may-11-2026 Boston Technology Review en PressRelease 2026-04-27T12:56:29+00:00 Telos Corporation to Announce First Quarter 2026 Financial Results on May 11, 2026 https://ml.globenewswire.com/media/9035d484-18b8-4406-85df-b2a5e5a1ff53/small/telos2010-2c-web-jpg.jpg https://www.bostontechnologyreview.com/article/908443559-new-generation-consumer-group-moves-from-ai-infrastructure-announcement-to-deployment-with-signed-server-purchase-order Boston Technology Review en PressRelease 2026-04-27T12:40:12+00:00 New Generation Consumer Group Moves from AI Infrastructure Announcement to Deployment with Signed Server Purchase Order https://ml.globenewswire.com/media/OTUxMjhlM2MtZWM0ZC00YTVmLWEwMTQtNGI4YTVkOTFjM2NiLTUwMDE2MTM2Mi0yMDI2LTA0LTI3LWVu/tiny/New-Generation-Consumer-Group-.png https://www.bostontechnologyreview.com/article/908443320-akari-therapeutics-secures-australian-patent-approval-further-expanding-global-protection-of-its-proprietary-ph1-rna-splicing-modulator-adc-payload Boston Technology Review en PressRelease 2026-04-27T12:35:00+00:00 Akari Therapeutics Secures Australian Patent Approval, Further Expanding Global Protection of Its Proprietary PH1 RNA Splicing Modulator ADC Payload https://ml.globenewswire.com/media/8d978f50-07a9-40a3-be69-45f51ccd94d9/small/akari-logo-1-jpg.jpg https://www.bostontechnologyreview.com/article/908443541-roadzen-s-vehiclecare-wins-major-claims-mandate-from-one-of-india-s-largest-insurers-expected-to-generate-over-10-million-in-annual-revenue Boston Technology Review en PressRelease 2026-04-27T12:31:01+00:00 Roadzen’s VehicleCare Wins Major Claims Mandate from One of India’s Largest Insurers, Expected to Generate Over $10 Million in Annual Revenue https://ml.globenewswire.com/media/5101ee32-4aaf-4552-aa26-c4ed796caf72/small/roadzen-png.png https://www.bostontechnologyreview.com/article/908443309-satellogic-schedules-first-quarter-fiscal-year-2026-results-conference-call-on-tuesday-march-12-2026-at-8-00-a-m-eastern-time Boston Technology Review en PressRelease 2026-04-27T12:31:00+00:00 Satellogic Schedules First Quarter Fiscal Year 2026 Results Conference Call on Tuesday, March 12, 2026 at 8:00 a.m. Eastern Time https://ml.globenewswire.com/media/d2d0c386-2a99-4434-aa48-fc69a11ff8a7/small/satellogic-logo-png.png https://www.bostontechnologyreview.com/article/908443298-cytodyn-announces-first-patient-dosed-in-expanded-access-program-for-leronlimab-in-triple-negative-breast-cancer Boston Technology Review en PressRelease 2026-04-27T12:30:00+00:00 CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer https://ml.globenewswire.com/media/3b426b4d-6299-4c23-9f95-058174a5b7be/small/new-logo-png.png https://www.bostontechnologyreview.com/article/908443326-big-digital-energy-inc-announces-colocation-agreement-with-the-endeavor-group Boston Technology Review en PressRelease 2026-04-27T12:30:00+00:00 Big Digital Energy, Inc. Announces Colocation Agreement with the Endeavor Group https://ml.globenewswire.com/media/aaa43c21-c5d1-47c0-9df9-32ff9aafb86a/small/2-removebg-preview-png.png https://www.bostontechnologyreview.com/article/908443367-tenaya-therapeutics-announces-late-breaking-oral-presentation-of-new-clinical-data-from-ridge-1-phase-1b-2-clinical-trial-of-tn-401-gene-therapy-in Boston Technology Review en PressRelease 2026-04-27T12:30:00+00:00 Tenaya Therapeutics Announces Late-Breaking Oral Presentation of New Clinical Data from RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy in Adults with PKP2-Associated ARVC at ASGCT 2026 https://ml.globenewswire.com/media/95a7de9f-2b24-4ff3-9b57-f8a35e8c049f/small/tenaya-logo-fullcolor-rgb-jpg.jpg https://www.bostontechnologyreview.com/article/908443425-erasca-to-host-conference-call-and-webcast-to-discuss-preliminary-phase-1-dose-escalation-data-for-potentially-best-in-class-pan-ras-molecular-glue Boston Technology Review en PressRelease 2026-04-27T12:30:00+00:00 Erasca to Host Conference Call and Webcast to Discuss Preliminary Phase 1 Dose Escalation Data for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015 https://ml.globenewswire.com/media/266fe248-70d0-4904-b12e-e0d5a990f816/small/erascatm-logo-png.png https://www.bostontechnologyreview.com/article/908443489-cycurion-delivers-on-2026-profitable-growth-strategy-with-6-million-win-and-112-million-backlog-powered-by-innovative-ai-solutions Boston Technology Review en PressRelease 2026-04-27T12:30:00+00:00 Cycurion Delivers on 2026 Profitable Growth Strategy with $6 Million Win and $112 Million Backlog Powered by Innovative AI Solutions https://ml.globenewswire.com/media/YzFlYzgyMDUtNzA4OC00NTk2LTgzZmItMTg0ZWRiNmNiNjk2LTEzMTA0NTAtMjAyNi0wNC0yNy1lbg==/tiny/Cycurion.png https://www.bostontechnologyreview.com/article/908443499-medipharm-labs-positioned-to-serve-growing-u-s-pharmaceutical-and-clinical-research-demand-following-cannabis-rescheduling Boston Technology Review en PressRelease 2026-04-27T12:30:00+00:00 MediPharm Labs Positioned to Serve Growing U.S. Pharmaceutical and Clinical Research Demand Following Cannabis Rescheduling https://ml.globenewswire.com/media/7a534238-60aa-4187-979d-8f4d83fa58c1/small/medipharm-logo-jpg.jpg https://www.bostontechnologyreview.com/article/908443458-vivopower-targets-1-9-million-annualized-ebitda-uplift-from-enrollment-of-norway-data-center-into-statnett-reserve-markets-demand-response-program Boston Technology Review en PressRelease 2026-04-27T12:18:00+00:00 VivoPower Targets $1.9 Million Annualized EBITDA Uplift from Enrollment of Norway Data Center into Statnett Reserve Markets Demand Response Program https://ml.globenewswire.com/media/372e7e36-8f34-46d9-8cbc-c2284310ed5f/small/picture1-png.png https://www.bostontechnologyreview.com/article/908443519-microsoft-isv-binary-stream-software-announces-partner-excellence-award-winners-ahead-of-directions-north-america-2026 Boston Technology Review en PressRelease 2026-04-27T12:15:32+00:00 Microsoft ISV Binary Stream Software Announces Partner Excellence Award Winners Ahead of Directions North America 2026 https://ml.globenewswire.com/media/NDYyYTBjNTUtZGMzNS00YzI2LWIzNDEtZWVmNjdlNjljZTJkLTEzMjI5NTgtMjAyNi0wNC0yNy1lbg==/tiny/Binary-Stream-Software-Inc-.png https://www.bostontechnologyreview.com/article/908439011-oncolytics-aligns-with-fda-on-planned-pivotal-anal-cancer-study Boston Technology Review en PressRelease 2026-04-27T12:10:00+00:00 Oncolytics Aligns with FDA on Planned Pivotal Anal Cancer Study https://ml.globenewswire.com/media/f0121259-b2be-4290-90a3-0d2c3b243aed/small/oncolytics-biotech-jpg.jpg https://www.bostontechnologyreview.com/article/908438890-new-data-presented-at-hrs-2026-show-short-term-holter-monitoring-misses-a-large-proportion-of-af-recurrence-post-ablation-and-clinically-significant Boston Technology Review en PressRelease 2026-04-27T12:05:00+00:00 New Data Presented at HRS 2026 Show Short-Term Holter Monitoring Misses a Large Proportion of AF Recurrence Post-Ablation and Clinically Significant Arrhythmias in Pregnancy https://ml.globenewswire.com/media/e2eba87d-aa8b-4436-9f66-9ebf27f727e5/small/irhythm-rgb-indigo-jpg.jpg https://www.bostontechnologyreview.com/article/908439006-terns-pharmaceuticals-announces-fda-breakthrough-therapy-designation-granted-to-tern-701-for-certain-patients-with-chronic-myeloid-leukemia Boston Technology Review en PressRelease 2026-04-27T12:05:00+00:00 Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia https://ml.globenewswire.com/media/cfd0bb0d-8a9b-4de4-92ce-47e8018cf3d9/small/terns-logo-rgbs-jpg.jpg https://www.bostontechnologyreview.com/article/908438868-iovance-biotherapeutics-to-report-first-quarter-2026-financial-results-and-corporate-updates-on-thursday-may-7-2026 Boston Technology Review en PressRelease 2026-04-27T12:01:00+00:00 Iovance Biotherapeutics to Report First Quarter 2026 Financial Results and Corporate Updates on Thursday, May 7, 2026 https://ml.globenewswire.com/media/d0986bd6-4603-4e31-8ed1-f23b3e123605/small/iovance-jpg.jpg https://www.bostontechnologyreview.com/article/908439043-ardelyx-announces-abstract-accepted-for-poster-presentation-at-the-nkf-s-spring-clinical-meetings Boston Technology Review en PressRelease 2026-04-27T12:01:00+00:00 Ardelyx Announces Abstract Accepted for Poster Presentation at the NKF’s Spring Clinical Meetings https://ml.globenewswire.com/media/cee4ae6d-7a85-44bf-9c02-87e7fa934ec2/small/ardelyx-logo-rgb-jpg.jpg https://www.bostontechnologyreview.com/article/908438770-superdial-announces-strategic-partnership-with-guardian-to-modernize-dental-provider-data-attestation Boston Technology Review en PressRelease 2026-04-27T12:00:00+00:00 SuperDial Announces Strategic Partnership with Guardian to Modernize Dental Provider Data Attestation https://ml-eu.globenewswire.com/media/889e437a-62ab-4b8b-b4f2-4ff35a0aa880/small/superdial-logo-with-icon-and-text-png.png https://www.bostontechnologyreview.com/article/908438833-evaxion-promotes-birgitte-r-n-to-joint-role-of-chief-scientific-and-chief-operating-officer Boston Technology Review en PressRelease 2026-04-27T12:00:00+00:00 Evaxion promotes Birgitte Rønø to joint role of Chief Scientific and Chief Operating Officer https://ml-eu.globenewswire.com/media/19d0d69c-7f37-4d3b-8f26-2866d4ec3311/small/evaxion-deepblue-rgb-png.png https://www.bostontechnologyreview.com/article/908438847-opus-genetics-to-participate-in-leading-medical-conferences-in-may-2026 Boston Technology Review en PressRelease 2026-04-27T12:00:00+00:00 Opus Genetics to Participate in Leading Medical Conferences in May 2026 https://ml.globenewswire.com/media/468baef1-3b2d-4353-a17e-cb41b45ee6ef/small/opus-rgb-r-jpg.jpg https://www.bostontechnologyreview.com/article/908438864-biovie-to-host-virtual-kol-event-to-discuss-the-phase-2-study-of-bezisterim-for-the-treatment-of-parkinson-s-disease-ahead-of-topline-data-in-2q26-on Boston Technology Review en PressRelease 2026-04-27T12:00:00+00:00 BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson's Disease ahead of Topline Data in 2Q26, on May 7, 2026 https://ml.globenewswire.com/media/f437d04b-c089-46eb-bca8-7ef64f68bc9b/small/biovie-logo-jpg.jpg https://www.bostontechnologyreview.com/article/908438879-one-stop-systems-to-report-first-quarter-2026-financial-results Boston Technology Review en PressRelease 2026-04-27T12:00:00+00:00 One Stop Systems to Report First Quarter 2026 Financial Results https://ml.globenewswire.com/media/79e2cfd1-4552-49a9-85a0-a44777661e4f/small/oss-png.png https://www.bostontechnologyreview.com/article/908438897-microchip-increases-manufacturing-capacity-of-its-hydrogen-masers Boston Technology Review en PressRelease 2026-04-27T12:00:00+00:00 Microchip Increases Manufacturing Capacity of its Hydrogen Masers https://ml.globenewswire.com/media/443d82a7-09a7-4ecd-a1b6-6884351a2b14/small/mchp-logo-vertical-4c-jpg.jpg https://www.bostontechnologyreview.com/article/908438899-kaltura-unveils-avatar-powered-roleplay-solution-for-enterprise-training-and-simulations Boston Technology Review en PressRelease 2026-04-27T12:00:00+00:00 Kaltura Unveils Avatar-Powered Roleplay Solution for Enterprise Training and Simulations https://ml.globenewswire.com/media/584e487b-dd12-4a20-a5b1-c42f4579d369/small/kaltura-logo-vertical-colorsun-blacktext-small.png https://www.bostontechnologyreview.com/article/908438904-real-world-data-on-exparel-shows-reduced-opioid-use-and-lower-total-medical-costs-in-medicare-patients-undergoing-total-hip-arthroplasty Boston Technology Review en PressRelease 2026-04-27T12:00:00+00:00 Real-World Data on EXPAREL® Shows Reduced Opioid Use and Lower Total Medical Costs in Medicare Patients Undergoing Total Hip Arthroplasty https://ml.globenewswire.com/media/3e502c92-e576-46b6-b602-a177ab0f5044/small/pacira-biosciences-tm-logo-rgb-v2025-300dpi-adj-png.png https://www.bostontechnologyreview.com/article/908438912-cerence-to-announce-fiscal-second-quarter-results-on-may-7-2026 Boston Technology Review en PressRelease 2026-04-27T12:00:00+00:00 Cerence to Announce Fiscal Second Quarter Results on May 7, 2026 https://ml.globenewswire.com/media/873690ee-866c-4dea-9808-10aecc02890f/small/cerence-ai-logo-full-color-h-1-png.png https://www.bostontechnologyreview.com/article/908438973-piano-software-names-nick-worth-ceo Boston Technology Review en PressRelease 2026-04-27T12:00:00+00:00 Piano Software Names Nick Worth CEO https://ml.globenewswire.com/media/d1e97a8c-2908-4de8-9945-782ebd318731/small/piano-logo-jpg.jpg https://www.bostontechnologyreview.com/article/908438991-feedonomics-unlocks-agentic-discovery-with-agentic-catalog-exports Boston Technology Review en PressRelease 2026-04-27T12:00:00+00:00 Feedonomics Unlocks Agentic Discovery with Agentic Catalog Exports https://ml.globenewswire.com/media/a953dd36-af2e-4b21-a5e8-45f93eb35143/small/commerce-logo-jpg.jpg https://www.bostontechnologyreview.com/article/908438995-humacyte-to-host-virtual-kol-event-to-discuss-atev-for-arteriovenous-av-access-for-hemodialysis-patients-on-april-28-2026 Boston Technology Review en PressRelease 2026-04-27T12:00:00+00:00 Humacyte to Host Virtual KOL Event to Discuss ATEV for Arteriovenous (AV) Access for Hemodialysis Patients on April 28, 2026 https://ml.globenewswire.com/media/e81aff26-ead8-404d-aebb-159b45c3e7b1/small/huma-logo-png.png https://www.bostontechnologyreview.com/article/908439016-avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury Boston Technology Review en PressRelease 2026-04-27T12:00:00+00:00 Avalyn Strengthens Leadership Team to Support Long-Term Growth with Appointments of Industry Leaders Adam Golden and Frank Salisbury https://ml.globenewswire.com/media/84d7bff4-ce17-433b-8c71-aa20c30f9f43/small/avalyn-logo-final-png.png https://www.bostontechnologyreview.com/article/908439017-magnite-unveils-new-ai-powered-intelligent-assistance-and-agentic-execution-capabilities-empowering-media-owners-and-buyers Boston Technology Review en PressRelease 2026-04-27T12:00:00+00:00 Magnite Unveils New AI-Powered Intelligent Assistance and Agentic Execution Capabilities, Empowering Media Owners and Buyers https://ml.globenewswire.com/media/NmZiNGRkN2ItNDg0MS00YTViLThjYTEtMGYxNDU4ZjgzMDI4LTEwMjkwMDQtMjAyNi0wNC0yNy1lbg==/tiny/Magnite-Inc-.png https://www.bostontechnologyreview.com/article/908439020-replimune-to-present-at-the-2026-american-society-of-clinical-oncology-asco-annual-meeting Boston Technology Review en PressRelease 2026-04-27T12:00:00+00:00 Replimune to Present at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting https://ml.globenewswire.com/media/NzU1N2M2NzEtNmRkNS00ODQ0LTg0YmQtZTVjMDZhZTRlNjQ1LTExMjIxMDEtMjAyNi0wNC0yNy1lbg==/tiny/Replimune-Inc-.png https://www.bostontechnologyreview.com/article/908439030-pharmala-executes-binding-letter-of-intent-for-formation-of-special-purpose-vehicle-to-develop-patented-novel-mdxx-molecule-apa-01 Boston Technology Review en PressRelease 2026-04-27T12:00:00+00:00 PharmAla Executes Binding Letter of Intent for Formation of Special Purpose Vehicle to Develop Patented Novel MDXX Molecule APA-01 https://ml.globenewswire.com/media/20158980-8674-43e3-a0be-a10dca42410d/small/pharmala-biotech-logo-800-x-422-png.png https://www.bostontechnologyreview.com/article/908439097-identity-digital-launches-neutral-dns-anchored-identity-standard-for-ai-agents Boston Technology Review en PressRelease 2026-04-27T12:00:00+00:00 Identity Digital Launches Neutral, DNS-Anchored Identity Standard for AI Agents https://ml.globenewswire.com/media/0f78d257-0174-4aa9-9384-33be1538a3c3/medium/solving-agentic-accountability.png https://www.bostontechnologyreview.com/article/908439098-apollomics-reports-full-year-2025-financial-results-and-provides-clinical-updates-and-business-progress Boston Technology Review en PressRelease 2026-04-27T12:00:00+00:00 Apollomics Reports Full Year 2025 Financial Results and Provides Clinical Updates and Business Progress https://ml.globenewswire.com/media/5d278096-e1c2-4350-b583-bca455f23b4b/small/apollomics-color-logo-1147x445-jpg.jpg https://www.bostontechnologyreview.com/article/908439135-arcutis-submits-supplemental-new-drug-application-to-the-fda-for-zoryve-roflumilast-cream-0-05-to-expand-indication-for-treatment-of-atopic Boston Technology Review en PressRelease 2026-04-27T12:00:00+00:00 Arcutis Submits Supplemental New Drug Application to the FDA for ZORYVE® (roflumilast) Cream 0.05% to Expand Indication for Treatment of Atopic Dermatitis to Infants Down to 3 Months https://ml.globenewswire.com/media/1b166f47-afb1-44f1-91be-2d73e97c0ec3/small/arcutis-logo-png.png https://www.bostontechnologyreview.com/article/908439155-global-e-to-announce-financial-results-for-the-first-quarter-2026-on-may-13-2026 Boston Technology Review en PressRelease 2026-04-27T12:00:00+00:00 Global-e to Announce Financial Results for the First Quarter 2026 on May 13, 2026 https://ml.globenewswire.com/media/92952a2a-00ff-44cf-8c8c-d13300b285f2/small/global-e-logo-rgb-jpg.jpg https://www.bostontechnologyreview.com/article/908439160-belite-bio-announces-oral-presentation-at-the-retinal-therapeutics-innovation-summit Boston Technology Review en PressRelease 2026-04-27T12:00:00+00:00 Belite Bio Announces Oral Presentation at the Retinal Therapeutics Innovation Summit https://ml.globenewswire.com/media/7f86ac70-6347-41c6-a622-e7000c42ad35/small/belite-bio-logo-digital-full-color-png.png https://www.bostontechnologyreview.com/article/908439169-alpha-compute-ai-gpu-launch-update-first-large-scale-nvidia-blackwell-cluster Boston Technology Review en PressRelease 2026-04-27T12:00:00+00:00 Alpha Compute AI GPU Launch Update; First Large-Scale NVIDIA Blackwell Cluster https://ml.globenewswire.com/media/c3705597-9575-42f8-915f-a5f923655778/small/aclogobluelarge-png.png https://www.bostontechnologyreview.com/article/908434497-clearmind-medicine-announces-evaluation-of-its-psychedelic-based-treatment-meai-for-potential-fda-breakthrough-therapy-designation Boston Technology Review en PressRelease 2026-04-27T11:41:00+00:00 Clearmind Medicine Announces Evaluation of its Psychedelic-Based Treatment (MEAI) for Potential FDA Breakthrough Therapy Designation https://ml.globenewswire.com/media/bd17cbf4-8124-4f86-8a4c-1fafbb6785af/small/logo-jpg.jpg https://www.bostontechnologyreview.com/article/908434376-tovecimig-demonstrates-statistically-significant-benefit-in-companion-002-randomized-phase-2-3-study-in-patients-with-biliary-tract-cancer Boston Technology Review en PressRelease 2026-04-27T11:30:00+00:00 Tovecimig Demonstrates Statistically Significant Benefit in COMPANION-002 Randomized Phase 2/3 Study in Patients with Biliary Tract Cancer https://ml.globenewswire.com/media/b8470129-5d30-4368-8074-d77404b65be8/small/compass-logo-rgb-outlines-png.png https://www.bostontechnologyreview.com/article/908434384-medicus-pharma-ceo-meets-with-lawmakers-on-energy-commerce-committee-on-capitol-hill Boston Technology Review en PressRelease 2026-04-27T11:30:00+00:00 Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill https://ml.globenewswire.com/media/0f5af1d1-dfba-4810-baac-d1922c0558c1/small/medicus-logo-rgb-05-aspect-1500px-globe-newswire-2-jpg.jpg https://www.bostontechnologyreview.com/article/908434404-hcw-biologics-delivers-a-major-update-for-its-t-cell-engager-program-revealing-mechanism-of-action-and-validating-tissue-factor-as-target-for Boston Technology Review en PressRelease 2026-04-27T11:30:00+00:00 HCW Biologics Delivers a Major Update for its T-Cell Engager Program Revealing Mechanism of Action and Validating Tissue Factor as Target for Treatment of Solid Tumors https://ml.globenewswire.com/media/5689edc3-6997-43a0-a20c-b34dc5f99b0f/small/hcw-logo-full-color-600x-jpeg-2-jpg.jpg https://www.bostontechnologyreview.com/article/908434422-nervgen-pharma-strengthens-leadership-team-with-appointment-of-keith-vendola-as-chief-financial-officer Boston Technology Review en PressRelease 2026-04-27T11:30:00+00:00 NervGen Pharma Strengthens Leadership Team with Appointment of Keith Vendola as Chief Financial Officer https://ml.globenewswire.com/media/bb42d0ef-06b6-4b90-8389-ca991092aa37/small/nervgen-logo-updated-globenewswire-png.png https://www.bostontechnologyreview.com/article/908434429-cormedix-therapeutics-announces-positive-topline-results-from-phase-iii-respect-trial-assessing-rezzayo-for-the-prophylaxis-of-invasive-fungal Boston Technology Review en PressRelease 2026-04-27T11:30:00+00:00 CorMedix Therapeutics Announces Positive Topline Results from Phase III ReSPECT Trial Assessing REZZAYO® for the Prophylaxis of Invasive Fungal Diseases in Allogeneic Hematopoietic Stem Cell Transplantation Patients https://ml.globenewswire.com/media/a14d732c-3f66-4a3c-96bb-7fc8ba5797bb/small/crmd-logo-jpg.jpg https://www.bostontechnologyreview.com/article/908434491-alterity-therapeutics-receives-positive-fda-feedback-following-second-type-c-meeting-on-ath434-phase-3-program-in-multiple-system-atrophy Boston Technology Review en PressRelease 2026-04-27T11:25:00+00:00 Alterity Therapeutics Receives Positive FDA Feedback Following Second Type C Meeting on ATH434 Phase 3 Program in Multiple System Atrophy https://ml.globenewswire.com/media/0771a9a2-2ac1-4a63-9767-a2b1df74af27/small/alterity-png.png https://www.bostontechnologyreview.com/article/908430292-sagimet-biosciences-announces-pricing-of-175-0-million-underwritten-offering-of-series-a-common-stock Boston Technology Review en PressRelease 2026-04-27T11:15:04+00:00 Sagimet Biosciences Announces Pricing of $175.0 Million Underwritten Offering of Series A Common Stock https://ml.globenewswire.com/media/e944daed-3f71-402b-bb23-82149e5c0d26/small/sagimet-logo-for-light-bg-fin-png.png https://www.bostontechnologyreview.com/article/908429872-allot-to-release-first-quarter-2026-results-and-host-conference-call-on-may-12-2026 Boston Technology Review en PressRelease 2026-04-27T11:06:51+00:00 Allot to Release First Quarter 2026 Results and Host Conference Call on May 12, 2026 https://ml-eu.globenewswire.com/media/de6a7a3a-fc53-4a4e-9772-6201603d4770/small/allot-logo-no-tag-jpg.jpg https://www.bostontechnologyreview.com/article/908429876-aeluma-appoints-willy-rachmady-vice-president-of-strategic-partnerships-and-ecosystem Boston Technology Review en PressRelease 2026-04-27T11:00:00+00:00 Aeluma Appoints Willy Rachmady Vice President of Strategic Partnerships and Ecosystem https://ml.globenewswire.com/media/b1015780-d7ba-46d1-b327-269ba03ba2ab/small/almu-logo-jpg.jpg https://www.bostontechnologyreview.com/article/908429883-fulcrum-therapeutics-announces-recent-business-highlights-and-financial-results-for-first-quarter-2026 Boston Technology Review en PressRelease 2026-04-27T11:00:00+00:00 Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2026 https://ml.globenewswire.com/media/3434fc83-4bcf-4d3c-ae26-23e5b1fd4252/small/fulcrum-logo-primary-full-color-rgb-large-png.png https://www.bostontechnologyreview.com/article/908429887-recognized-for-best-use-of-tech-in-hr-vetty-wins-bronze-stevie-in-2026-american-business-awards Boston Technology Review en PressRelease 2026-04-27T11:00:00+00:00 Recognized for Best Use of Tech in HR, Vetty Wins Bronze Stevie® in 2026 American Business Awards® https://ml.globenewswire.com/media/21066ed2-0106-4e28-a0e5-427d9228a3d1/small/vetty-logo-2022-png.png https://www.bostontechnologyreview.com/article/908429911-palomino-laboratories-inc-closes-15-million-at-4-share Boston Technology Review en PressRelease 2026-04-27T11:00:00+00:00 Palomino Laboratories Inc. Closes $15 Million at $4/share https://ml.globenewswire.com/media/3aaf8e51-09af-4413-8132-02b7b76f4c76/small/pl-tm-white-and-gold-on-blue-jpg.jpg https://www.bostontechnologyreview.com/article/908429920-sionna-therapeutics-completes-enrollment-in-precision-cf-phase-2a-trial-evaluating-nbd1-stabilizer-sion-719-added-to-standard-of-care-in Boston Technology Review en PressRelease 2026-04-27T11:00:00+00:00 Sionna Therapeutics Completes Enrollment in PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, Added to Standard of Care in Participants with Cystic Fibrosis https://ml.globenewswire.com/media/0cda8c25-e758-4f0d-86f2-875df8411a9a/small/sionna-png.png https://www.bostontechnologyreview.com/article/908430027-secura-bio-announces-journal-of-clinical-oncology-publication-of-final-results-of-duvelisib-primo-phase-2-trial-in-relapsed-refractory-peripheral Boston Technology Review en PressRelease 2026-04-27T11:00:00+00:00 Secura Bio Announces Journal of Clinical Oncology Publication of Final Results of Duvelisib PRIMO Phase 2 Trial in Relapsed/Refractory Peripheral T-cell Lymphoma https://ml.globenewswire.com/media/0c6ab6dc-8076-44dc-acba-60a586a93721/small/securabio-brand-rgb-logo-fullcolor-png.png https://www.bostontechnologyreview.com/article/908430111-oruka-therapeutics-announces-positive-week-16-data-for-orka-001-from-the-ongoing-everlast-a-phase-2a-trial-in-moderate-to-severe-plaque-psoriasis Boston Technology Review en PressRelease 2026-04-27T11:00:00+00:00 Oruka Therapeutics Announces Positive Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Phase 2a Trial in Moderate-to-Severe Plaque Psoriasis https://ml.globenewswire.com/media/3950d2d7-850d-459a-9e42-07c642a841c5/small/oruka-full-color-jpg.jpg https://www.bostontechnologyreview.com/article/908430156-intellia-therapeutics-reports-positive-phase-3-results-in-hereditary-angioedema-marking-a-global-first-for-in-vivo-gene-editing Boston Technology Review en PressRelease 2026-04-27T11:00:00+00:00 Intellia Therapeutics Reports Positive Phase 3 Results in Hereditary Angioedema, Marking a Global First for In Vivo Gene Editing https://ml.globenewswire.com/media/9b6b17bb-c8a4-4009-b5f8-8cadb4d2296a/small/intellia-jpg.jpg https://www.bostontechnologyreview.com/article/908430163-intellia-therapeutics-initiates-rolling-submission-of-biologics-license-application-to-fda-for-lonvoguran-ziclumeran-lonvo-z-as-a-one-time-treatment Boston Technology Review en PressRelease 2026-04-27T11:00:00+00:00 Intellia Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for Lonvoguran Ziclumeran (lonvo-z) as a One-Time Treatment for Hereditary Angioedema https://ml.globenewswire.com/media/9b6b17bb-c8a4-4009-b5f8-8cadb4d2296a/small/intellia-jpg.jpg https://www.bostontechnologyreview.com/article/908430186-harrow-to-report-first-quarter-2026-financial-results-after-market-close-on-may-11-2026 Boston Technology Review en PressRelease 2026-04-27T11:00:00+00:00 Harrow To Report First Quarter 2026 Financial Results After Market Close on May 11, 2026 https://ml.globenewswire.com/media/8e0382bf-e00a-4591-87aa-4e90001aabea/small/bw-harrow-logo-cmyk-wtag-wr-jpg.jpg https://www.bostontechnologyreview.com/article/908430187-altimmune-announces-closing-of-225-million-oversubscribed-public-offering-of-securities Boston Technology Review en PressRelease 2026-04-27T11:00:00+00:00 Altimmune Announces Closing of $225 Million Oversubscribed Public Offering of Securities https://ml.globenewswire.com/media/362fbdfa-dc07-456c-9908-9e042540158a/small/altimmune-logo-png.png https://www.bostontechnologyreview.com/article/908430189-cardiff-oncology-to-host-key-opinion-leader-discussion-on-onvansertib-s-promising-single-agent-activity Boston Technology Review en PressRelease 2026-04-27T11:00:00+00:00 Cardiff Oncology to Host Key Opinion Leader Discussion on Onvansertib’s Promising Single-Agent Activity https://ml.globenewswire.com/media/916adb81-8173-4fbe-8095-c284c4f44cd3/small/cardiff-jpg.jpg https://www.bostontechnologyreview.com/article/908430195-sagimet-biosciences-provides-strategic-and-corporate-updates Boston Technology Review en PressRelease 2026-04-27T11:00:00+00:00 Sagimet Biosciences Provides Strategic and Corporate Updates https://ml.globenewswire.com/media/e944daed-3f71-402b-bb23-82149e5c0d26/small/sagimet-logo-for-light-bg-fin-png.png https://www.bostontechnologyreview.com/article/908430198-ocular-therapeutix-to-participate-in-may-scientific-and-investor-conferences Boston Technology Review en PressRelease 2026-04-27T11:00:00+00:00 Ocular Therapeutix™ to Participate in May Scientific and Investor Conferences https://ml.globenewswire.com/media/20ee0f50-7288-4f81-8546-f2ad2050ddbf/small/ocul-logo-jpg.jpg https://www.bostontechnologyreview.com/article/908430200-seer-board-of-directors-unanimously-rejects-revised-unsolicited-proposal-from-radoff-jec-group Boston Technology Review en PressRelease 2026-04-27T11:00:00+00:00 Seer Board of Directors Unanimously Rejects Revised Unsolicited Proposal from Radoff-JEC Group https://ml.globenewswire.com/media/a5aaadad-13a1-4dbd-8ba2-d57cbbc610fb/small/seer-brandmark-rgb-full-jpg.jpg https://www.bostontechnologyreview.com/article/908430206-ligand-to-acquire-xoma-royalty-further-accelerating-profit-growth-and-strengthening-ligand-s-position-as-a-leading-biopharma-royalty-aggregator Boston Technology Review en PressRelease 2026-04-27T11:00:00+00:00 Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator https://ml.globenewswire.com/media/46cbb269-1ae4-4441-a46a-d782ffb436dc/small/xoma-royalty-2c-png.png https://www.bostontechnologyreview.com/article/908430207-ligand-to-acquire-xoma-royalty-further-accelerating-profit-growth-and-strengthening-ligand-s-position-as-a-leading-biopharma-royalty-aggregator Boston Technology Review en PressRelease 2026-04-27T11:00:00+00:00 Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator  https://ml.globenewswire.com/media/1fe91aa2-494e-4b30-89e8-cad771bbaabf/small/new-ligand-logo-png.png https://www.bostontechnologyreview.com/article/908430211-moonfox-alternative-data-redefines-china-insights-at-neudata-hong-kong-summit-a-triple-threat-of-online-offline-and-transactional-data Boston Technology Review en PressRelease 2026-04-27T11:00:00+00:00 MoonFox Alternative Data Redefines China Insights at Neudata Hong Kong Summit: A Triple-Threat of Online, Offline, and Transactional Data https://ml.globenewswire.com/media/36c8f943-f1d6-4fc9-ae7e-52270f6b5096/medium/joken-liu-presented-at-neudata.jpg https://www.bostontechnologyreview.com/article/908430252-youxin-technology-announces-to-strategically-acquire-yatop-worth-10-8-million-shares-to-expand-global-tiktok-ecosystem-and-digital-commerce Boston Technology Review en PressRelease 2026-04-27T11:00:00+00:00 Youxin Technology Announces to Strategically Acquire YATOP Worth $10.8 Million Shares to Expand Global TikTok Ecosystem and Digital Commerce Capabilities https://ml.globenewswire.com/media/b427409e-182c-4359-98f9-0cbc3cf76525/small/logo-jpg.jpg https://www.bostontechnologyreview.com/article/908425638-fulcrum-therapeutics-appoints-josh-lehrer-to-its-board-of-directors Boston Technology Review en PressRelease 2026-04-27T10:55:00+00:00 Fulcrum Therapeutics Appoints Josh Lehrer to its Board of Directors https://ml.globenewswire.com/media/3434fc83-4bcf-4d3c-ae26-23e5b1fd4252/small/fulcrum-logo-primary-full-color-rgb-large-png.png https://www.bostontechnologyreview.com/article/908425640-eton-pharmaceuticals-announces-initiation-of-clinical-study-for-product-candidate-et-700 Boston Technology Review en PressRelease 2026-04-27T10:50:00+00:00 Eton Pharmaceuticals Announces Initiation of Clinical Study for Product Candidate ET-700 https://ml.globenewswire.com/media/db07cafa-b35c-4d61-a1a1-d330caf67ad2/small/eton-logo-png.png https://www.bostontechnologyreview.com/article/908418157-owlting-group-nasdaq-owls-to-announce-full-year-2025-financial-results Boston Technology Review en PressRelease 2026-04-27T10:03:00+00:00 OwlTing Group (NASDAQ: OWLS) to Announce Full Year 2025 Financial Results https://ml.globenewswire.com/media/f044d335-9e0f-4fe4-8ffd-3414828e326f/small/owlting-logo-primary-png.png https://www.bostontechnologyreview.com/article/908418144-relay-therapeutics-announces-clinical-data-for-zovegalisib-plus-atirmociclib-triplet-combination-supportive-of-further-development-in-frontline Boston Technology Review en PressRelease 2026-04-27T10:00:00+00:00 Relay Therapeutics Announces Clinical Data for Zovegalisib plus Atirmociclib Triplet Combination Supportive of Further Development in Frontline Metastatic Breast Cancer https://ml.globenewswire.com/media/079b6db5-ce81-4a81-9cde-d97f86c569ae/small/logo-banner-small-png.png https://www.bostontechnologyreview.com/article/908401914-ataibeckley-and-psypan-receive-a-silver-award-in-2026-patient-participant-index-reflecting-ongoing-commitment-to-participant-informed-research Boston Technology Review en PressRelease 2026-04-27T08:05:00+00:00 AtaiBeckley and PsyPAN Receive a Silver Award in 2026 Patient Participant Index, Reflecting Ongoing Commitment to Participant-Informed Research https://ml.globenewswire.com/media/cea08bf4-0562-45ed-af5c-c9376c48a6eb/small/ataibeckley-horizontal-2color-png.png https://www.bostontechnologyreview.com/article/908401976-simply-contact-launches-ai-call-simulation-onboarding-program-for-multilingual-contact-center-agents Boston Technology Review en PressRelease 2026-04-27T08:04:43+00:00 Simply Contact Launches AI Call Simulation Onboarding Program for Multilingual Contact Center Agents https://ml.globenewswire.com/media/b955e110-ba76-4073-8ad3-5e9b85ac861f/medium/simply-contact-launches-ai-call-simulation-onboarding-progra.jpg https://www.bostontechnologyreview.com/article/908395646-full-year-results-for-the-year-ended-31-december-2025 Boston Technology Review en PressRelease 2026-04-27T07:23:29+00:00 Full Year Results for the year ended 31 December 2025 https://ml.globenewswire.com/media/c4b6af1c-c16f-4ab6-81f1-2cec4970ea26/small/bango-master-logo-hires-png.png https://www.bostontechnologyreview.com/article/908392269-veson-and-veracity-by-dnv-partner-to-streamline-verified-emissions-reporting-and-commercial-voyage-management Boston Technology Review en PressRelease 2026-04-27T07:00:00+00:00 Veson and Veracity by DNV partner to streamline verified emissions reporting and commercial voyage management https://ml.globenewswire.com/media/6f117f11-95c0-45f2-8699-98a2ced03b1a/medium/veson-nautical.jpg https://www.bostontechnologyreview.com/article/908381127-ose-immunotherapeutics-welcomes-fda-orphan-drug-designation-granted-to-pegrizeprument-vel-101-for-prevention-of-organ-rejection-in-heart-transplant Boston Technology Review en PressRelease 2026-04-27T05:30:00+00:00 OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101) for Prevention of Organ Rejection in Heart Transplant Patients https://ml-eu.globenewswire.com/media/e79ae2c6-fc13-4a02-9759-4ecc9c4fdb22/small/ose-logo-horizontal-rvb-png.png https://www.bostontechnologyreview.com/article/908381134-ose-immunotherapeutics-se-f-licite-de-l-octroi-de-la-d-signation-de-m-dicament-orphelin-par-la-fda-du-pegrizeprument-vel-101-pour-la-pr-vention-du Boston Technology Review en PressRelease 2026-04-27T05:30:00+00:00 OSE Immunotherapeutics se félicite de l'octroi de la désignation de médicament orphelin par la FDA du pegrizeprument (VEL-101) pour la prévention du rejet d’organe dans la transplantation cardiaque https://ml-eu.globenewswire.com/media/e79ae2c6-fc13-4a02-9759-4ecc9c4fdb22/small/ https://www.bostontechnologyreview.com/article/908378484-santhera-erh-lt-positive-stellungnahme-des-chmp-zur-ausweitung-der-anwendung-von-agamree-vamorolon-bei-p-diatrischen-dmd-patienten-ab-zwei-jahren Boston Technology Review en PressRelease 2026-04-27T05:00:00+00:00 Santhera erhält positive Stellungnahme des CHMP zur Ausweitung der Anwendung von AGAMREE® (Vamorolon) bei pädiatrischen DMD-Patienten ab zwei Jahren in der EU https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/ https://www.bostontechnologyreview.com/article/908378495-santhera-receives-positive-chmp-opinion-to-expand-agamree-vamorolone-use-in-pediatric-dmd-patients-aged-two-and-older-in-the-eu Boston Technology Review en PressRelease 2026-04-27T05:00:00+00:00 Santhera Receives Positive CHMP Opinion to Expand AGAMREE® (vamorolone) Use in Pediatric DMD Patients Aged Two and Older in the EU https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/logo-jpg.JPG https://www.bostontechnologyreview.com/article/908371330-vcitychain-dpos-mainnet-officially-launches-building-a-high-performance-autonomous-public-blockchain-for-a-new-web4-infrastructure-ecosystem Boston Technology Review en PressRelease 2026-04-27T04:00:00+00:00 Vcitychain DPoS Mainnet Officially Launches Building a High-Performance Autonomous Public Blockchain for a New Web4 Infrastructure Ecosystem https://ml.globenewswire.com/media/69b81850-755b-480c-b410-8679e67ac75d/small/screenshot-2026-04-26-093134-png.png https://www.bostontechnologyreview.com/article/908367164-dark-horse-consulting-group-and-porton-advanced-announce-memorandum-of-understanding-providing-a-streamlined-path-to-conducting-iits-in-china Boston Technology Review en PressRelease 2026-04-27T03:30:00+00:00 Dark Horse Consulting Group and Porton Advanced Announce Memorandum of Understanding Providing a Streamlined Path to Conducting IITs in China https://ml.globenewswire.com/media/b96e7c60-949b-4a7d-9d4e-8d9766cf8c87/small/2025-dhcg-logo-color-jpg.jpg https://www.bostontechnologyreview.com/article/908364932-here-technologies-deepens-collaboration-with-china-s-intelligent-driving-innovator-neuehct-to-accelerate-global-noa-expansion Boston Technology Review en PressRelease 2026-04-27T03:11:16+00:00 HERE Technologies deepens collaboration with China’s intelligent driving innovator neueHCT to accelerate global NOA expansion https://ml-eu.globenewswire.com/media/df5dd056-7ac1-4ee2-aa19-025172aeaeb1/medium/here-technologies-deepens-collaboration-with-chinas-intellig.JPG https://www.bostontechnologyreview.com/article/908364933-here-technologies-neuehct-noa Boston Technology Review en PressRelease 2026-04-27T03:11:16+00:00 HERE Technologies、中国のインテリジェントドライビング分野を牽引するneueHCTとの協業を強化し、グローバルNOA展開を加速 https://ml-eu.globenewswire.com/media/df5dd056-7ac1-4ee2-aa19-025172aeaeb1/medium/here-technologies-neuehct-noa.JPG https://www.bostontechnologyreview.com/article/908364935-here-technologies-neuehct-noa Boston Technology Review en PressRelease 2026-04-27T03:11:16+00:00 HERE Technologies深化与中国智能驾驶创新企业智驾新程neueHCT合作，加速NOA全球布局 https://ml-eu.globenewswire.com/media/df5dd056-7ac1-4ee2-aa19-025172aeaeb1/medium/here-technologiesneuehct-noa.JPG https://www.bostontechnologyreview.com/article/908349713-crypto-news-today-alphapepe-binance-listing-talks-accelerate-whilst-xrp-price-prediction-sets-target-at-8-00 Boston Technology Review en PressRelease 2026-04-27T00:30:00+00:00 Crypto News Today: AlphaPepe Binance Listing Talks Accelerate whilst XRP Price Prediction Sets Target at $8.00 https://ml.globenewswire.com/media/896bf817-3ed3-4685-a620-611e0caa8b41/medium/alphapepe.jpg https://www.bostontechnologyreview.com/article/908341796-crypto-news-alphapepe-presale-nears-1m-raise-whilst-solana-price-prediction-eyes-120 Boston Technology Review en PressRelease 2026-04-26T23:30:00+00:00 Crypto News: AlphaPepe Presale Nears $1M Raise whilst Solana Price Prediction Eyes $120 https://ml.globenewswire.com/media/58449edb-950c-423e-9e0b-6afe445e648d/medium/alphapepe-presale.jpg https://www.bostontechnologyreview.com/article/908282227-oruka-therapeutics-to-host-conference-call-to-report-week-16-data-for-orka-001-from-the-ongoing-everlast-a-trial-on-april-27-2026 Boston Technology Review en PressRelease 2026-04-26T16:00:00+00:00 Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Trial on April 27, 2026 https://ml.globenewswire.com/media/3950d2d7-850d-459a-9e42-07c642a841c5/small/oruka-full-color-jpg.jpg https://www.bostontechnologyreview.com/article/907620144-learn-to-spot-scams-launches-comprehensive-digital-security-platform-to-combat-rising-online-fraud-and-identity-theft Boston Technology Review en PressRelease 2026-04-25T18:38:50+00:00 Learn to Spot Scams Launches Comprehensive Digital Security Platform to Combat Rising Online Fraud and Identity Theft https://www.bostontechnologyreview.com/article/908187413-crypto-news-alphapepe-presale-crosses-960-000-raised-as-bitcoin-price-prediction-aims-at-200-000 Boston Technology Review en PressRelease 2026-04-26T02:00:00+00:00 Crypto News: AlphaPepe Presale Crosses $960,000 Raised as Bitcoin Price Prediction Aims at $200,000 https://ml.globenewswire.com/media/85ee43ed-6f26-415f-92df-433d205e745e/medium/alphapepe.jpg https://www.bostontechnologyreview.com/article/908174833-how-to-sell-a-business-without-a-broker-new-course-helps-owners-keep-more-of-their-money Boston Technology Review en PressRelease 2026-04-26T00:30:00+00:00 How to Sell a Business Without a Broker: New Course Helps Owners Keep More of Their Money https://pressranger.s3.us-west-1.amazonaws.com/3235787/HPJeschke1-24-23-2.png https://www.bostontechnologyreview.com/article/908162646-crypto-news-alphapepe-defi-exchange-progress-hits-1-000-demo-users-whilst-dogecoin-price-prediction-points-to-1-00 Boston Technology Review en PressRelease 2026-04-25T23:00:00+00:00 Crypto News: AlphaPepe DeFi Exchange Progress Hits 1,000 Demo Users whilst Dogecoin Price Prediction Points To $1.00 https://ml.globenewswire.com/media/09516d07-1b1e-451d-8188-b2d6b0d71ac3/medium/alphapepe.jpg https://www.bostontechnologyreview.com/article/908097107-study-shows-implicity-s-new-agnostic-cloud-based-ai-algorithm-further-reduces-false-alerts-even-after-manufacturer-ai-filtering-in-modern-devices Boston Technology Review en PressRelease 2026-04-25T15:00:00+00:00 Study Shows Implicity’s New Agnostic Cloud-Based AI Algorithm Further Reduces False Alerts Even After Manufacturer AI Filtering in Modern Devices https://ml.globenewswire.com/media/d7822800-7d4d-420d-aa7f-89a50a370756/small/implicity-logo-jpg.jpg